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In a recent review article of the health effects
of coarse airborne particles on health,
Brunekreef and Forsberg (2005) call for spe-
cial consideration in studying and regulating
coarse particulate matter [PM with aerody-
namic diameter 2.5–10 µm (PM2.5–10)] sepa-
rately from fine particulate matter (PM2.5).
Epidemiologic evidence indicates that coarse
PM had as strong a short-term effect (or
stronger) as fine PM on asthma, chronic
obstructive pulmonary disease (COPD), car-
diac, and respiratory hospital admissions
(Brunekreef and Forsberg 2005; Burnett et al.
1997, 1999; Chen et al. 2004; Sheppard et al.
1999). There is a growing body of work
examining the mechanisms of effect of fine
PM on heart rate variability (HRV) and sys-
temic inflammation in susceptible populations
such as the elderly, individuals with COPD,
and individuals with recent myocardial infarc-
tion, hypertension, diabetes, or ischemic heart
disease (Chuang et al. 2005; Liao et al. 1999;
O’Neill et al. 2005; Park et al. 2005; Sullivan
et al. 2005; Wheeler et al. 2006). However,
few if any studies have examined potential
mechanisms of effect of coarse PM to explain
the epidemiologic associations between
increased mortality/morbidity and exposure to
ambient coarse PM.
Coarse PM can be distinguished from
other particulate sizes by the content of bio-
active microbial products. Becker et al. have
reported that coarse PM activates macrophages
and monocytes in vitro in a toll-like receptor
(TLR)2- and TLR4-dependent fashion, with a
significant fraction of this biologic activity
being ascribed to endotoxin (Becker et al.
2002; Soukup and Becker 2001). Alexis et al.
(2006) recently showed that in healthy indi-
viduals, endotoxin on inhaled coarse PM elicits
innate immune responses in vivo on airway
macrophages. Likewise, endotoxin found in
ambient PM samples (Mueller-Anneling et al.
2004), indoor dust samples (Michel et al.
1996; Pacheco et al. 2003; Thorne et al.
2005), and via personal ambient air monitor-
ing (Rabinovitch et al. 2005) was linked to
increased respiratory morbidity in children,
demonstrating the likely importance of endo-
toxin containing coarse PM. Adachi et al.
(2006) found that intraperitoneally adminis-
tered endotoxin decreases heart rate variability
measures such as rMSSD (root mean square
of successive differences in normal-to-normal
R-R intervals) and spectral density at low and
high frequencies in a mouse model. Moreover,
we and others have found that bronchial chal-
lenge with endotoxin also induces systemic
inflammatory effects in asthmatics, even at
inhaled doses that do not cause overt airway
or systemic symptoms (Alexis et al. 2004;
Michel et al. 1992, 1997).
Collectively, these observations led to the
hypothesis that coarse PM has the ability to
induce respiratory, cardiovascular, and sys-
temic effects in humans and perhaps more so
in those with preexisting airway disease such
as asthma. As in our previous panel study on
the effects of ambient PM on highway patrol
officers (Riediker et al. 2004), we employed a
repeated-measures design and examined a
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INTRODUCTION: We investigated whether markers of airway and systemic inflammation, as well as
heart rate variability (HRV) in asthmatics, change in response to fluctuations in ambient particulate
matter (PM) in the coarse [PM with aerodynamic diameter 2.5–10 µm (PM2.5–10)] and fine
(PM2.5) size range. 
METHODS: Twelve adult asthmatics, living within a 30-mile radius of an atmospheric monitoring
site in Chapel Hill, North Carolina, were followed over a 12-week period. Daily PM2.5–10 and
PM2.5 concentrations were measured separately for each 24-hr period. Each subject had nine clinic
visits, at which spirometric measures and peripheral blood samples for analysis of lipids, inflamma-
tory cells, and coagulation-associated proteins were obtained. We also assessed HRV [SDNN24HR
(standard deviation of all normal-to-normal intervals in a 24-hr recording), ASDNN5 (mean of the
standard deviation in all 5-min segments of a 24-hr recording)] with four consecutive 24-hr ambu-
latory electrocardiogram measurements. Linear mixed models with a spatial covariance matrix
structure and a 1-day lag were used to assess potential associations between PM levels and cardio-
pulmonary end points. 
RESULTS: For a 1-µg/m3 increase in coarse PM, SDNN24HR, and ASDNN5 decreased 3.36% (p =
0.02), and 0.77%, (p = 0.05) respectively. With a 1-µg/m3 increase in coarse PM, circulating
eosinophils increased 0.16% (p = 0.01), triglycerides increased 4.8% (p = 0.02), and very low-density
lipoprotein increased 1.15% (p = 0.01). No significant associations were found with fine PM, and
none with lung function. 
CONCLUSION: These data suggest that small temporal increases in ambient coarse PM are sufficient
to affect important cardiopulmonary and lipid parameters in adults with asthma. Coarse PM may
have underappreciated health effects in susceptible populations.
KEY WORDS: asthma, coarse PM, heart rate variability, inflammatory markers, lipids, systemic
inflammation. Environ Health Perspect 115:709–714 (2007). doi:10.1289/ehp.9499 available via
http://dx.doi.org/ [Online 18 January 2007]
panel of 12 adults with asthma to determine
the effects of two PM size fractions on a) cir-
culating immune cells and prothrombotic fac-
tors, b) the induction of airway inflammation,
and c) changes in cardiac autonomic function.
Asthmatics were studied because they were
considered more likely to demonstrate car-
diopulmonary and systemic effects from
ambient PM than healthy populations. 
Materials and Methods
Population and study design. Twelve adults
with persistent asthma (ranging from mild to
severe disease), living within a 30-mile radius
of the PM ambient exposure monitor located
at the U.S. Environmental Protection Agency
(EPA) research facility in Chapel Hill, North
Carolina, were each monitored over a 12-week
period. The study was designed to evaluate a
range of ambient PM concentrations. Each
subject made nine clinic visits, five the first
week and four spaced randomly over the subse-
quent 6–11 weeks. Enrollment occurred from
9 September 2003 to 19 July 2004. Subjects
were excluded from the study if they had a
medical history of cystic fibrosis, COPD,
chronic bronchitis, recurrent pneumonia, pul-
monary embolism, congestive heart failure,
vocal cord dysfunction, chest wall deformity,
autoimmune disease, diabetes, existing heart
disease, or any health problem that precluded
following study protocol. Potential study sub-
jects were excluded if they smoked more than
two packs of cigarettes in the year before study
enrollment. The University of North Carolina
(UNC) Biomedical Institutional Review Board
reviewed and approved the research protocol as
did the U.S. EPA. All study subjects gave
informed consent before participation.
Study logistics. At enrollment, we obtained
demographic information and medical histo-
ries using a standardized questionnaire. During
the first clinic visit, participants underwent a
physical exam, phlebotomy, electrocardiogram
(ECG), and a pulmonary function test. The
subsequent eight clinic visits included a phle-
botomy, physical examination, and pulmonary
function testing. Eight of 12 volunteers con-
sented to epicutaneous skin testing during the
study period. Four volunteers were unwilling
to discontinue antihistamine therapy and were
not skin tested. Skin prick tests (SPT) for
house dust mites, German cockroach, an
Eastern tree mix, grass mix, two mold mixes,
guinea pig, rat, cat, and mouse were per-
formed, with four of the eight tested subjects
having a positive response to at least one aller-
gen, three persons having completely negative
skin tests, and one having invalid results due
to a nonreactive histamine control test. Use of
asthma medications was recorded, including
anti-inflammatory controller medication
(inhaled corticosteroids, oral corticosteroids,
oral leukotriene inhibitors), and rescue
medication (short-acting beta2 agonist,
albuterol). Asthma severity was classified using
the National Heart, Lung, and Blood Institute
(NHLBI) Asthma Guidelines (NHLBI 2003).
Daily asthma symptoms and medication use
were recorded electronically in a personal digi-
tal assistant (PDA). 
PM air pollution measurements. Daily
ambient coarse (PM2.5–10) and fine (PM2.5)
size PM were measured separately for each
24-hr period using a Dichotomous Partisol-
Plus Sequential Air Sampler (Model 2025-D;
Rupprecht & Patashnick Co., Inc., Albany,
NY) located on the roof of the U.S. EPA
Human Studies Facility on the UNC campus
in Chapel Hill. Coarse PM is usually not
directly measured, only calculated as the dif-
ference between PM10 and PM 2.5. However,
we directly measured coarse PM and fine PM
separately within the same air stream using a
method that first separates the particles
according to their size fraction before collect-
ing them. PM mass retained on the Teflon fil-
ters (47 mm 2.0 µm; Teflo Pallflex Gelman
Scientific; Pall Corporation, Ann Arbor, MI)
was weighed on a microbalance in an EPA
weight chamber. 
Lung function, airway inflammation,
and airway cell surface marker expression.
Lung function was measured at each clinic visit
using a spirometer (Sensormedics Corporation,
Yorba Linda, CA). Pre-bronchodilator values
were used. Induced sputum was performed
according to previously published procedures
(Alexis et al. 2001, 2004, 2005), and airway
inflammation measures included enumeration
of inflammatory cells (neutrophils, eosino-
phils, monocytes, macrophages). Flow cytom-
etry was performed using a FACSORT
(Becton Dickinson, Franklin Lakes, NJ) as
previously described (Alexis et al. 2005,
2006). Macrophages, monocytes, neutrophils,
and lymphocytes in sputum were labeled with
fluorescent monoclonal antibodies, identified,
and gated based on light scatter properties
(FSC: cell size; SSC: cell granularity) and
positive expression for CD45 (panleukocyte
marker), HLA-DR/CD14 (macrophages/
monocytes), CD16/FcgRIII (neutrophils),
CD16-/FcgRIII (eosinophils), and CD3
(lymphocytes). The appropriate isotypic con-
trols were used. Analysis was performed using
the Cell Quest software (Becton Dickinson)
and receptor expression was expressed as
mean fluorescence intensity (MFI). 
Circulating cells, lipids, and proteins.
During each clinic visit, blood was drawn
using standardized procedures for phle-
botomy, collection, and storage. Blood sam-
ples were taken from antecubital veins and
collected into vacuum tubes. Blood samples
were sent to LabCorp (Burlington, NC) for a
complete blood count analysis that included
differential leukocyte analysis.
Plasma from these samples was distributed
into aliquots and stored at –80°C until assayed
in our laboratory using commercially available
ELISA kits. Analytes of interest included inter-
leukin-6, (R&D Systems, Minneapolis, MN),
protein C, prothrombin, plasminogen, Factor
VII, Factor IX (Enzyme Research Labs, South
Bend, IN), plasminogen activator inhibitor
type 1 (Oncogene Science, Cambridge, MA),
von Willebrand factor (Diagnostica Stago,
Asnières-sur-Seine, France), and fibrinogen
(DiaSorin, Stillwater, MN). 
HRV assessment using ambulatory ECG.
During the first week of the study, changes in
HRV parameters were measured using an
ambulatory ECG (Zymed Inc., Camarillo,
CA). After a 20-min rest, ECG R-waves were
recorded from participants in a supine posi-
tion. Subjects wore the ambulatory ECG
recorders for four 24-hr periods. Each morn-
ing, at the beginning of the clinic visit, volun-
teers rested quietly in a supine position for
20 min followed by a specific 10-min period
of recording (again in the supine position).
The final 10-min period was used specifically
for frequency domain analysis of HRV. Each
24-hr period of ECG data was analyzed by a
cardiac electrophysiology nurse specialist and
reviewed by a cardiologist. We measured
ASDNN5 (the mean of the standard deviation
in all 5-min segments of a 24-hr recording),
SDANN5 (the standard deviation of the aver-
age of normal-to-normal intervals in all 5-min
segments of a 24-hr recording), SDNN24HR
[the standard deviation of all normal-to-
normal R-R intervals in a 24-hr recording
(milliseconds)], SDNN7min taken from the
7-min rest period each morning, and rMSSD.
Additional measurements in the time domain
included pNN50 [the percentage of differ-
ences between adjacent normal to normal
intervals that are > 50 msec for both a 24-hr
period (pNN50_24), and a 7-min period
(pNN50_7), measured after 20 min supine]
and the mean cycle length of normal R-R
intervals (MCL). Mean heart rate (beats per
minute), a general marker of autonomic func-
tion, was derived from the RR-interval record. 
SDNN24HR was used to estimate the
overall modulation of autonomic nervous sys-
tem function and reflects total variability,
whereas rMSSD estimates high-frequency vari-
ations in heart rate and primarily reflects
parasympathetic activity. ASDNN5 includes
respiratory-mediated parasympathetic input as
well as baroreceptor-mediated sympathetic and
parasympathetic input. To address the issue of
HRV circadian cycles, we examined several
HRV parameters from the same time each
day, pNN50 measured for 7 min, and SDNN
measured for a 7-min period during the 20-min
rest period at the same time each morning.
We used a fast Fourier transformation to
calculate the power spectral density curve.
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We used the area under the curve in the
high-frequency range (0.15–0.40 Hz) to esti-
mate parasympathetic modulation of variabil-
ity. And we used low-frequency (LF) power
(0.04–0.15 Hz) to estimate the joint contri-
bution of parasympathetic and sympathetic
influences on HRV, although it reflects pri-
marily sympathetic modulation. 
Statistical analyses. We used linear mixed
models with restricted maximum-likelihood
estimation to assess potential time-varying
associations of coarse and fine PM with spu-
tum measurements, lung function, measures
of HRV, proteins associated with plasma
coagulation, hemostatic and inflammatory
markers, and serum lipids. A 24-hr or 1-day
lag of effect was assumed; the daily 24-hr PM
concentrations were matched with the out-
come measurements of the subsequent day.
We also evaluated 2- and 3-day lags (Peel
et al. 2005; Pekkanen et al. 2002; Peters et al
2004; Ruckerl et al. 2006; Timonen et al.
2006; Zeka et al. 2005) for all outcomes.
Models included the time-varying factors
of atmospheric average daily temperature,
humidity, and pressure. Time-invariant sub-
ject specific characteristics (such as age and
sex) were not included in the final models
because no differences in main effect esti-
mates were seen with the time-invariant vari-
ables. Each subject served as his or her own
control by study design. Daily PM concentra-
tions and atmospheric variables were modeled
as fixed effects. 
The models included a random intercept
for each subject to help account for between-
subject variability. The correlation matrix
structure with the repeated measures statement
was specified as a spatial power function with
an exponential time term of the form f (dijj ′) =
ρdijj ′. This parameterization accounts for the
variable time between clinic visits for each indi-
vidual; in particular, for the ith person corr(Yij ,
Yij ′) = ρdijj ′, where dijj ´ is the time (in days)
between responses Yij and Yij ′ for the ith per-
son. All statistical computations were per-
formed with SAS software version 8.2 (SAS
Institute Inc., Cary, NC) using the “proc
mixed” (mixed models) procedure. To evaluate
potential outliers we examined the regression
residuals. Plots of the residuals versus predicted
values were constructed and examined for
outliers. In addition, we also used the inter-
active data analysis feature in SAS to construct
crude bivariate plots of coarse PM and main
outcomes variables for all study subjects and
for each individual. There was no evidence of
significant influence by outliers or the models
being driven by one or two subjects. 
Results
Environmental measures. The mean (± SD)
coarse PM concentration for the 284 days
sampled was 5.3 ± 2.8 µg/m3 with a range of
0–14.6 µg/m3; for fine PM, the mean con-
centration was 12.5 ± 6.0 µg/m3 with a range
of 0.6–37 µg/m3. The average temperature
was 17.6°C, and the relative humidity 49.1%.
Coarse and fine PM were not strongly corre-
lated with relative humidity or barometric
pressure, although temperature was statisti-
cally significantly correlated (0.48 and 0.61,
respectively, p < .01). The fine PM and PM10
levels never exceeded the 1990 U.S. National
Ambient Air Quality 24-hr standard of
65 µg/m3 and 150 µg/m3, respectively (U.S.
EPA 1990). Summary statistics for air pollu-
tion and weather characteristics are presented in
Table 1. Subsequent results are presented for a
1-day lag. We evaluated 2- and 3-day lags and
did not find any patterns of statistically signifi-
cant associations with the 2- or 3-day lags with
measures of HRV, blood lipids, coagulation, or
lung function and markers of inflammation. 
Subjects. The 12 subjects (3 male, 9 female)
ranged in age from 21 to 50 years, with a mean
of 33 years. Three subjects were African
American (Table 2). Most asthmatics had mild
disease severity (7 persistent, 2 intermittent),
two had moderate disease and one severe.
Percent predicted FEV1 (forced expiratory vol-
ume at 1 sec) values for the subjects ranged
from 65 to 118%, with a mean of 96%. Four
of 12 subjects were atopic (positive skin prick
test), four were unable/unwilling to withdraw
from antihistamine use but had previously
tested positive for allergies before study enroll-
ment, and four had invalid skin prick test
results (negative histamine result or positive
saline result) but reported allergic symptoms.
All subjects took short acting beta-agonist res-
cue medication, and 10 of the 12 were taking
controller medication (9 inhaled cortico-
steroids, 1 leukotriene inhibitor). Summary
statistics (means, standard deviations, and
range) of the HRV, circulating proteins, and
lipids for the twelve study subjects are pre-
sented in the Supplemental Material Table 1
(available online at http://www.ehponline.org/
docs/2007/9499/suppl.pdf). They are within
the normal range of healthy individuals, and
comparable to other recently published studies
(Liao et al. 2004). 
Changes in spirometry, symptoms, induced
sputum parameters, and total particle size
fractions. No consistent associations between
either coarse PM or fine PM were found with
spirometric measurements, rescue beta-agonist
use, or reported symptoms; nor were associa-
tions found with measures of airway inflam-
mation [see Supplemental Material Tables 2
and 3, (including sputum macrophages,
monocytes, and neutrophils) available online
at http://www.ehponline.org/docs/2007/
9499/suppl.pdf]. 
HRV and total particle size fractions.
We observed statistically significant changes
in HRV associated with PM2.5–10 (Table 3).
For a 1-µg/m3 increase in PM2.5–10, heart
rate variability as measured by SDANN5,
SDNN24HR, and ASDNN5 decreased
3.76% (p = 0.02), 3.360% (p = 0.02), and
0.77% (p = 0.05), respectively. We found a
borderline association with pNN50_7min (p =
0.07), and no association with the 7-min
SDNN (SDNN7min). High-frequency power,
a measure of parasympathetic modulation,
Coarse PM and systemic inflammation in asthmatics
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Table 1. Ambient air characteristics and PM concentrations (n = 284 days).
Spearman ρ
Concentration correlation coefficients
Variable (mean ± SD) Range PM2.5–10 PM2.5
PM2.5–10 (coarse) 5.3 ± 2.8 (0 to 14.6) 1 0.46*
PM2.5 (fine) 12.5 ± 6.0 (0.6 to 37.1) 0.46* 1
PM10 (total) 17.5 ± 7.8 (1.4 to 45.6) 0.73* 0.90*
Temperature (°C) 17.6 ± 8.5 (–5.0 to 32.9) 0.60* 0.48*
Relative humidity (%) 49.1 ± 14.5 (10.5 to 91.6) 0.13** 0.16
Barometric pressure (mm Hg) 756.1 ± 5.9 (741 to 770) 0.11 –0.01
*p < 0.01. **p < 0.05.
Table 2. Demographic characteristics of study par-
ticipants (n = 12).
Category No. (%)a
Sex 
Female 9 (75)
Race/ethnicity
African American 3 (25)
White 7 (58)
Latino 1 (8)
Asian 1 (8)
NHLBI severity classification
Severe 1 (8)
Moderate persistent 2 (17)
Mild persistent 7 (58)
Mild intermittent 2 (17)
Asthma medication 
Antiinflammatory controller medication 10 (83)
Inhaled corticosteroids
Fluticasone/salmeterol 5 (42)
Budesonide 3 (25)
Fluticasone 1 (8)
Leukotriene inhibitor (montelukast) 1 (8)
Beta-agonists (albuterol) 12 (100)
Allergies
Antihistamine therapy 4 (33)
Subjects SPT 8 (67)
SPT positive 4 (33)
Symptoms, SPT negative 3 (25)
Uninterpretable SPT 1 (8)
IgE concentration (IU/mL) 166.7 (3–755)
Percent predicted FEV1 [%, mean (range)] 0.96 (65–118) 
Age [years, mean (range)] 33.17 (21–50)
aPercentages are rounded to the near whole number.
decreased 0.46% (p = 0.01) per 1-µg/m3
increase in coarse PM, indicating a decrease in
vagal autonomic input to the heart associated
with coarse PM. Similar patterns were not seen
for fine PM (see Supplemental Material Tables
4 and 5, available online at http://www.
ehponline.org/docs/2007/9499/suppl.pdf).
Circulating proteins, cells, and lipids and
total particle size fractions. Estimated regres-
sion coefficients (percent) and p-values for cir-
culating proteins, cells, and lipids associated
with coarse and fine PM are presented in
Table 4. For a 1-µg/m3 increase in coarse PM,
a 0.16% increase in circulating eosinophils (p =
0.01) was found. Ambient coarse PM was also
associated with changes in blood lipids. For a
1-µg/m3 increase in coarse PM, an increase of
4.8% in triglycerides (milligrams per deciliter)
(p = 0.02) and a 1.15% increase in very low-
density lipoprotein (VLDL) (milligrams per
deciliter) (p = 0.01) were found. After adjust-
ing for ambient temperature, relative baromet-
ric pressure, and relative humidity, the
association of the levels of blood coagulation–
related proteins (fibrinogen and plasminogen)
with coarse PM were of borderline significance
(p = 0.07, p = 0.08). For a 1-µg/m3 increase in
coarse PM, a decrease of 0.01% in plasmino-
gen (international units per milliliter) and
0.04% in fibrinogen concentration (milligrams
per milliliter) were found.
Other blood proteins and lipids revealed
no associations with either size fraction of
PM. Other circulating inflammatory cells
(basophils, monocytes, lymphocytes, or neu-
trophils) were not significantly associated with
coarse PM concentrations. C-reactive protein
was not statistically significantly associated
with increases in ambient coarse or fine PM
concentrations. No consistent statistically sig-
nificant relationships were seen for fine PM
(Table 5, Supplemental Material, available
online at http://www.ehponline.org/docs/
2007/9499/suppl.pdf).
Discussion
We examined airway and systemic responses to
exposure to ambient coarse (PM2.5–10) and fine
(PM2.5) PM in a cohort of adult asthmatics.
Recent reports suggest that coarse PM initiates
responses from airway cells in vivo in healthy
volunteers (Alexis et al. 2006) and may be an
underappreciated cause for respiratory and
systemic inflammation (Brunekreef and
Forsberg 2005). This study is the first to report
that relatively low concentrations of coarse PM
are associated with decreases in HRV, increases
in circulating eosinophils, and serum trigly-
cerides in adult asthmatics.
We were somewhat surprised that we did
not observe any relationship between coarse or
fine PM with rescue medication use, asthma
symptoms, lung function, or airway inflam-
matory markers in sputum samples. However,
10 of the 12 adult asthmatics in the present
study were treated with anti-inflammatory
controller medication for their disease, and 9
of the 12 had mild disease. It is possible that
anti-inflammatory treatment mitigated the
effect of PM in their airways, or that adults
with asthma are less susceptible to the effects
of PM than children with asthma [in whom
associations have been reported with coarse
PM and increased asthma admissions to hos-
pitals (Lin et al. 2002)]. Indeed, we have
observed that inhaled corticosteroids mini-
mizes the effect of inhaled endotoxin in asth-
matics (Alexis et al. 2001). Mar et al. (2004)
have reported that health outcomes associated
with coarse PM were more notable in children
with asthma than in adults with asthma. All
the ambient fine and coarse PM concentra-
tions in this panel study were well below the
current 1997 National Ambient Air Quality
Standards (U.S. EPA 1990), and the variabil-
ity in PM measurements was not very large
over the course of the study; this may not have
been sufficient to induce acute lung inflamma-
tion in adults with well-controlled asthma. We
did observe, however, a significant increase in
circulating eosinophils in this cohort that was
associated with coarse PM, suggesting a gen-
eral pro-allergic effect of coarse PM in asth-
matics, even in the absence of airway effects. 
Despite the lack of short-term effect of PM
on respiratory-tract biology in these asthmatics,
we found that both coarse and fine PM had a
significant effect on cardiac autonomic function
as reflected by changes in heart rate variability.
However, the associations between coarse PM
and HRV were stronger and more consistent
than with fine PM. In particular, greater effects
were noted between coarse PM exposure and
decreased high-frequency power (and percent
high-frequency power) in the frequency
domain, and decreased ASDNN5, SDANN5,
and SDNN24HR parameters in the time
domains. These measures are consistent with
decreased parasympathetic influence and vagal
tone. With respect to fine PM, there was a
modest association with two heart rate vari-
ability parameters (SDANN5 and rMSSD). 
Our HRV findings are consistent with
those of Gong et al. (2004), who reported
that mild asthmatic and normal volunteers
undergoing a controlled exposure to particulate
Yeatts et al.
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Table 4. Change in circulating proteins and hematologic and lipid indicesa per 1-µg/m3 increase in PM2.5–10
and PM2.5.
PM2.5–10 PM2.5
Estimated Estimated
regression regression
Outcome coefficient SE 95% CI p-Value coefficient SE 95% CI p-Value
Blood lipids
Triglycerides 4.78 2.02 0.81 to 8.74 0.02 –0.63 0.84 –2.29 to 1.02 0.46
VLDL 1.15 0.44 0.29 to 2.02 0.01 –0.17 0.22 –0.61 to 0.26 0.44
Total cholesterol 0.78 0.54 –0.28 to 1.84 0.15 –0.06 0.22 –0.49 to 0.36 0.77
Hematologic factors and circulating immune cells
Circulating eosinophils 0.16 0.06 0.04 to 0.28 0.01 –0.02 0.00 –0.02 to –0.02 0.27
Platelets –1.71 1.11 –3.89 to 0.47 0.13 –0.01 0.45 –0.88 to 0.86 0.98
Circulating proteins
Plasminogen –0.01 0.01 –0.02 to 0.00 0.08 0.00 0.00 –0.01 to 0.00 0.82
Fibrinogen –0.04 0.02 –0.08 to 0.00 0.07 0.00 0.01 –0.01 to 0.02 0.59
Von Willibrand factor –1.23 0.66 –2.53 to 0.06 0.07 –0.31 0.29 –0.87 to 0.25 0.28
Factor VII –0.90 0.85 –2.58 to 0.77 0.29 –0.65 0.33 –1.29 to –0.01 0.05
aAdjusted for relative temperature, pressure, and humidity.
Table 3. Change in HRV indicesa per 1-µg/m3 increase in PM2.5–10 and PM2.5.
PM2.5–10 PM2.5
Estimated Estimated
regression regression
coefficient SE p-Value 95% CI coefficient SE p-Value 95% CI
HRV
Max heart rate –1.95 0.88 0.03 –3.67 to –0.23 0.40 0.43 0.36 –0.45 to 1.24
ASDNN5 –0.77 0.37 0.05 –1.50 to –0.04 –0.07 0.15 0.63 –0.37 to 0.22
SDANN5 –3.76 1.53 0.02 –6.76 to –0.76 1.66 0.65 0.02 0.39 to 2.93
SDNN24HR (msec) –3.36 1.38 0.02 –6.06 to –0.65 1.16 0.58 0.06 0.02 to 2.29
rMSSD –0.75 0.53 0.16 –1.79 to 0.28 0.53 0.20 0.01 0.14 to 0.91
pNN50_24hour –0.50 0.27 0.07 –1.03 to 0.03 –0.06 0.11 0.58 –0.27 to 0.15
pNN50_7min –1.88 0.55 0.07 –2.95 to –0.81 0.47 0.42 0.27 –0.35 to 1.29
Low-frequency power –0.19 0.42 0.65 –1.01 to 0.63 –0.23 0.14 0.11 –0.51 to 0.05
Percent low frequency 0.57 1.08 0.60 –1.55 to 2.69 –0.78 0.41 0.07 –1.59 to 0.03
High-frequency power –0.46 0.17 0.01 –0.79 to –0.14 0.14 0.07 0.07 –0.01 to 0.28
Percent high frequency –2.14 0.94 0.03 –3.98 to –0.30 0.64 0.36 0.09 –0.07 to 1.34
Abbreviations: Max, maximum; pNN50_24hour and pNN50_7min, percentage of differences between adjacent normal-to-
normal intervals that are > 50 msec for either 24 hr or 7 min during resting period each morning.
aAdjusted for relative temperature, pressure, and humidity.
matter (80% of which was coarse PM by
mass) had a small but significant increase in
heart rate with decreased HRV in both normal
volunteers and asthmatics, though the effects
in normal volunteers were somewhat more
pronounced. Similarly, the decreases in HRV
measurements were comparable in magnitude
to decreases associated with fine PM in other
susceptible populations (Gold et al. 2000;
Holguin et al. 2003; Liao et al. 1999, 2004;
Park et al. 2005; Pope et al. 1999, 2004). For
example, in our study the estimated regression
coefficient for high frequency was a –4.6
[95% confidence interval (CI), –7.9 to –1.4]
percent change with a 10-µg/m3 increase in
coarse PM; Liao et al. (2004) reported an esti-
mated regression coefficient for high fre-
quency of 5.1 (95% CI, –8.0 to –2.1) with a
10-µg/m3 increase in fine PM.
There was also a near significant decrease
of plasma plasminogen, fibrinogen, and
von Willebrand factor (suggesting metabolic
consumption of these agents), and a significant
increase in triglycerides and VLDL related to
increased exposure to coarse PM. Recently
published clinical and epidemiologic studies
support the plausibility of the increased triglyc-
erides and VLDL association with elevated PM
as a potential mechanism for atherosclerotic
plaque progression (Chen and Nadziejko
2005; Kunzli et al. 2005; Sun et al. 2005;
Suwa et al. 2002; Tomao et al. 2002). 
Animal models and epidemiologic studies
have shown an association between PM expo-
sure and modified lipid levels. Suwa et al.
(2002) demonstrated in Watanabe heritable
hyperlipidemic rabbits that exposure to PM10
increased the total amount of lipids in aortic
lesions. Sun et al. (2005) showed in a murine
model that the lipid content in the aortic arch
increased 1.5-fold in mice fed a high-fat chow
diet and exposed to PM versus filtered air. In
an epidemiologic case–control study of traf-
fic-exposed police officers, the average values
of HDL cholesterol and triglycerides were ele-
vated in the exposed group versus an unex-
posed control group (Tomao et al. 2002).
With respect to HRV, lipids, and other circu-
lating markers of inflammation and PM expo-
sure, several recent studies have begun to
report an association that involves systemic
inflammation as a possible mechanism under-
lying the association. Yue et al. (2006) found
an association between abnormal HRV and
blood markers of inflammation in coronary
artery disease patients, and Sajadieh et al.
(2004) reported earlier that reduced HRV is
associated with subclinical inflammation in
middle-aged and elderly subjects with no
apparent heart disease. Consistent with these
reports are our findings in asthmatics that
ambient coarse PM is associated with
increased serum triglycerides, decreased HRV,
and increased circulating granulocytes
(eosinophils), suggesting a complex network
of interrelated pathways at work with respect
to the health effects of PM exposure.
This study is one of few with daily gravi-
metric measurements of both the coarse and
fine PM size fractions. Daily ambient fine PM
and coarse concentrations were measured with
a dichotomous Partisol-Plus Sequential Air
Sampler at the central site for 11 months. To
address potential spatial variation in coarse PM,
we conducted a validation study with samplers
at the site of the subject’s residence (Chen et al.
2007). The correlation between residential out-
door coarse PM mass concentrations and those
obtained from the central ambient monitoring
site were typically greater than r = 0.75. These
results show that although coarse PM mass con-
centrations were temporally variable, they were
relatively consistent spatially for distances up to
50 km (Chen et al. 2007). Thus, we are reason-
ably confident that for this panel study, the cen-
tral-site exposure is an acceptable proxy for
residential exposure of coarse PM. Fine PM
measured at a central site is recognized as a
good proxy for personal exposure (Koutrakis
et al. 2005; Sarnat et al. 2000; Williams 2003a,
2003b). The recent Williams et al. studies
(2003a, 2003b), conducted in Research
Triangle Park, North Carolina, over the course
of a 1-year period, indicate that fine PM con-
centrations are highly homogeneous with
respect to mass at distances approaching 70 km. 
Given that coarse PM is rich in biologic
material, particularly endotoxin, it may not
be surprising that we found effects of ambi-
ent coarse PM exposure that mimic those
seen with systemic endotoxin challenge.
Intravenous challenge with endotoxin is asso-
ciated with decreased HRV (associated with
increased risk for cardiac events), systemic
inflammation, and increases in serum triglyc-
erides and VLDL in human volunteers and in
animal models (Godin et al. 1996; Goldstein
et al. 1995; Hardardottir et al. 1995; Hudgins
et al. 2003; Levels et al. 2003; Voss et al.
2004). We and others have found that
bronchial challenge with endotoxin induces
systemic inflammatory effects as well, even at
inhaled doses that do not cause overt airway
or systemic symptoms (Alexis et al. 2004;
Michel et al. 1992, 1997). We have also
observed reduced airway cytokine and
macrophage responses in healthy volunteers
when they were exposed to coarse PM that
had been heated to deactivate biologic agents
(including denature endotoxin) versus PM
that had not been heated (Alexis et al. 2006).
These observations are consistent with our
hypothesis that persons with chronic inflam-
matory diseases of the airway have increased
responsiveness to biologic materials contained
in coarse particulates. 
Our panel study design allowed us to
examine both low-level ambient PM exposures
and their associated daily variability while at
the same having repeated intensive clinical
monitoring that would be impossible in field
epidemiologic studies. In summary, we found
that in repeated measures on a panel of 12
well-controlled asthmatics, 1-day lagged 24-hr
concentrations of ambient coarse PM were sig-
nificantly associated with decreased HRV,
increased circulating eosinophils, and increases
in serum triglycerides, indicating that coarse
PM may play an underappreciated role in pol-
lutant-induced cardiovascular events, even in
asthmatics using anti-inflammatory therapy.
We also report that neither low levels of ambi-
ent coarse nor fine PM had an effect on respi-
ratory symptoms, airway inflammation, or
lung function. Further study is needed to
identify the mechanisms of effect of coarse and
fine PM on systemic endpoints in healthy and
susceptible populations as well as the role of
endotoxin and other biologic components of
coarse PM on these outcomes.
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